APA

van Dijk E. H. C., Duits D. E. M., Versluis M., Luyten G. P. M., Bergen A. A. B., Kapiteijn E. W., de Lange M. J., Boon C. J. F. & van der Velden P. A. (20170201). Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients. : Medicine.

Chicago

van Dijk Elon H C, Duits Danique E M, Versluis Mieke, Luyten Gregrorius P M, Bergen Arthur A B, Kapiteijn Ellen W, de Lange Mark J, Boon Camiel J F and van der Velden Pieter A. 20170201. Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients. : Medicine.

Harvard

van Dijk E. H. C., Duits D. E. M., Versluis M., Luyten G. P. M., Bergen A. A. B., Kapiteijn E. W., de Lange M. J., Boon C. J. F. and van der Velden P. A. (20170201). Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients. : Medicine.

MLA

van Dijk Elon H C, Duits Danique E M, Versluis Mieke, Luyten Gregrorius P M, Bergen Arthur A B, Kapiteijn Ellen W, de Lange Mark J, Boon Camiel J F and van der Velden Pieter A. Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients. : Medicine. 20170201.